Results 141 to 150 of about 31,450 (226)

Glucokinase and the potential of glucokinase activation in type 2 diabetes [PDF]

Journal of Diabetes, 2019
openaire   +2 more sources

Treatment of Congenital Hyperinsulinism With a Novel, Long-acting Glucagon Analogue. [PDF]

JCEM Case Rep
Cannon M, Meline J, Mitteer LM, De Leon DD.   +3 more
europepmc   +1 more source

Thyroid dysfunction in African trypanosomiasis [PDF]

, 1993
Allolio, B., Arlt, W., Chrousos, G. P., Heppner, C., Mbulamberi, D., Petzke, F., Reincke, Martin, Siekmann, L., Vollmer, D., Winkelmann, W.   +9 more
core  

Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage [PDF]

, 2015

core   +1 more source

Safety profile of glucokinase activator AZD1656: systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy. [PDF]

Inflammopharmacology
Elsayed MM, Abdalla MM.
europepmc   +1 more source

Potential Factors of Diabetes in Gitelman Syndrome and the Choices of the Appropriate Hypoglycemic Drugs: A Literature Narrative Review. [PDF]

Curr Issues Mol Biol
Szubert I, Cader-Ptak A, Kwiatkowska E.
europepmc   +1 more source

Crystal structures of Escherichia coli glucokinase and insights into phosphate binding. [PDF]

Acta Crystallogr F Struct Biol Commun
Andrews J, Sakon J, Fan C.
europepmc   +1 more source

Balancing efficacy and safety: glucokinase activators in glycemic and metabolic management of type 2 diabetes mellitus-a meta-analysis. [PDF]

Endocr J
Zeng Y, Ye Y, Li Y, Yuan M, Hu J.
europepmc   +1 more source

Functional and Mechanistic Explanation for the Unique Clinical Success of the Glucokinase Activator Dorzagliatin in the Treatment of Type 2 Diabetes. [PDF]

Diabetes
Roman J, Yuan Y, Xu Y, Zhu Q, Wu S, Zhao F, Zhou X, Meng S, Han D, Sharp K, Chen L, Li C, Doliba NM.   +12 more
europepmc   +1 more source

Glucokinase Regulatory Protein [PDF]

, 2020
openaire   +1 more source